Jessica Perl - 29 Oct 2024 Form 3 Insider Report for Emergent BioSolutions Inc. (EBS)

Role
SVP, General Counsel, Corp Sec
Signature
/s/ Jessica Perl
Issuer symbol
EBS
Transactions as of
29 Oct 2024
Net transactions value
$0
Form type
3
Filing time
12 Nov 2024, 16:26:14 UTC
Next filing
11 Feb 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding EBS Common Stock 6,805 29 Oct 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding EBS Employee Stock Option (Right to buy) 29 Oct 2024 Common Stock 15,445 $12.95 Direct F1
holding EBS Employee Stock Option (Right to buy) 29 Oct 2024 Common Stock 18,000 $2.33 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Granted on February 10, 2023 and vesting in three equal installments beginning on the day prior to the anniversary date of the grant.
F2 Granted on March 13, 2024 and vesting in three equal installments beginning on the day prior to the anniversary date of the grant.

Remarks:

Exhibit list: Ex 24.1 - Power of Attorney